a developer of novel gene therapies to treat patients with sight-threatening ophthalmic diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, ADVM has been loosely correlated with CDTX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ADVM jumps, then CDTX could also see price increases.
Ticker / NAME | Correlation To ADVM | 1D Price Change % | ||
---|---|---|---|---|
ADVM | 100% | +3.16% | ||
CDTX - ADVM | 38% Loosely correlated | +2.14% | ||
IMNM - ADVM | 33% Poorly correlated | +0.07% | ||
VNDA - ADVM | 33% Poorly correlated | -0.80% | ||
KPTI - ADVM | 29% Poorly correlated | -1.41% | ||
CYTK - ADVM | 27% Poorly correlated | -3.01% | ||
More |